QTTB insider buying and SEC filings, explained
Q32 Bio Inc. · CIK 1661998
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$505K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 6, 2026 | Sale | Jodie Pope Morrison (CEO and Director) sold 3,221 shares at about $8.32 ($27K). Holdings down 1% to 340,038 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 5:30 PM ET |
| Oct 6, 2026 | Sale | Shelia M. Violette (Chief Scientific Officer) sold 917 shares at about $8.32 ($8K). Holdings down 1% to 126,854 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 5:30 PM ET |
| Oct 6, 2026 | Sale | Lee Kalowski (CFO) sold 1,301 shares at about $8.32 ($11K). Holdings down 1% to 137,170 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 14, 2026, 5:30 PM ET |
| Aug 25, 2026 | Sale | Lee Kalowski (CFO) sold 3,972 shares at $16.56 ($66K). Holdings down 3% to 138,471 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 27, 2026 |
| Aug 25, 2026 | Sale | Jodie Pope Morrison (CEO and Director) sold 9,845 shares at $16.56 ($163K). Holdings down 3% to 343,259 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 27, 2026 |
| Aug 25, 2026 | Sale | Shelia M. Violette (Chief Scientific Officer) sold 2,798 shares at $16.56 ($46K). Holdings down 2% to 127,771 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 27, 2026 |
| May 28, 2026 | Other purchase | Diyong Xu (Director and 10% owner) bought 1,875,000 Common Stock indirectly at $8.00 ($15.0M) in a private placement. New position of 625,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 1, 2026 |
| May 28, 2026 | Other purchase | ORBIMED ADVISORS LLC (Director and 10% owner) bought 1,875,000 Common Stock indirectly at $8.00 ($15.0M) in a private placement. New position of 625,000 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Jun 1, 2026 |
| Feb 25, 2026 | Sale | Lee Kalowski (CFO) sold 3,995 shares at about $4.51 ($18K). Holdings down 10% to 35,943 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 27, 2026 |
| Feb 25, 2026 | Sale | Jodie Pope Morrison (CEO and Director) sold 9,896 shares at about $4.51 ($45K). Holdings down 10% to 89,104 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 27, 2026 |
| Feb 25, 2026 | Sale | Shelia M. Violette (Chief Scientific Officer) sold 2,815 shares at about $4.51 ($13K). Holdings down 5% to 55,569 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 27, 2026 |
| Dec 2, 2025 | Sale | Jodie Pope Morrison (CEO and Director) sold 22,506 shares at $3.46 ($78K). Holdings down 19% to 99,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 4, 2025 |
| Dec 2, 2025 | Sale | Lee Kalowski (CFO) sold 9,072 shares at $3.46 ($31K). Holdings down 19% to 39,938 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 4, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow QTTB in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.